-

Anthem Completes Acquisition of Medicaid Plans in Missouri and Nebraska

INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE:ANTM) today announced that it has completed its acquisition of Medicaid plans in Missouri and Nebraska following the recent regulatory approval of WellCare’s merger with Centene Corporation.

“We are excited for the opportunity to provide our Medicaid expertise and support services to more than 300,000 new consumers in Missouri and Nebraska,” said Gail K. Boudreaux, President and Chief Executive Officer of Anthem, Inc. “Anthem’s focus on innovative, compassionate and comprehensive care is having a positive impact on the people we serve, as well as our local communities and the broader health system overall.”

This acquisition expands Anthem’s footprint to serve Medicaid beneficiaries in 23 states and the District of Columbia. The Missouri and Nebraska health plans will become wholly owned subsidiaries under the Government Business Division of Anthem, Inc.

About Anthem, Inc.

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 77 million people, including over 40 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner. For more information, please visit www.antheminc.com or follow @AnthemInc on Twitter.

Contacts

Investor Relations
Chris Rigg
Chris.rigg@anthem.com
or
Media
Jill Becher, 414-234-1573
Jill.becher@anthem.com

 Anthem, Inc.

NYSE:ANTM

Release Versions

Contacts

Investor Relations
Chris Rigg
Chris.rigg@anthem.com
or
Media
Jill Becher, 414-234-1573
Jill.becher@anthem.com

More News From  Anthem, Inc.

Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2026 results ahead of expectations. "Our second quarter results exceeded our outlook, supported by disciplined execution and improved operating performance across our diversified portfolio. We are raising our 2026 adjusted EPS guidance to at least $27.00 and accelerating targeted investments in the capabilities that matter most: medical cost management, member experience, provider connectivity, operating ef...

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2026 financial results on July 15, 2026, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-39...

New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act

INDIANAPOLIS--(BUSINESS WIRE)--The No Surprises Act was created to protect patients from unexpected medical bills. While those patient protections are working, new research from the Elevance Health Public Policy Institute suggests that the law's payment dispute process is producing unexpected results for some planned medical procedures. The findings come as federal IDR volume has grown far beyond initial projections, raising concerns that a process intended as a limited payment-dispute backstop...
Back to Newsroom